Tamara Kobiec

Dr. Tamara Kobiec

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2021 in Frontiers in Synaptic Neuroscience
Verified
Journal Article
Open access
PDF file
TKTamara Kobiec
Tamara Kobiec
MOMatilde Otero-Losada
Matilde Otero-Losada
GCGuenson Chevalier
Guenson Chevalier
LULucas Udovin
Lucas Udovin
SBSofía Bordet
Sofía Bordet
SPSantiago Pérez-Lloret
Santiago Pérez-Lloret
Parkinson’s disease (PD) is an extrapyramidal disorder characterized by neuronal degeneration in several regions of the peripheral and central nervous systems. It is the second most frequent neurodegenerative disease after Alzheimer’s. It has become a major health problem, affecting 1% of the world population over 60 years old and 3% of people beyond 80 years. The main histological findings are intracellular Lewy bodies composed of misfolded α-synuclein protein aggregates and loss of dopaminergic neurons in the central nervous system. Neuroinflammation, apoptosis, mitochondrial dysfunction, altered calcium homeostasis, abnormal protein degradation, and synaptic pathobiology have been put forward as mechanisms leading to cell death, α-synuclein deposition, or both. A progressive loss of dopaminergic neurons in the substantia nigra late in the neurodegeneration leads to developing motor symptoms like bradykinesia, tremor, and rigidity. The renin–angiotensin system (RAS), which is involved in regulating blood pressure and body fluid balance, also plays other important functions in the brain. The RAS is involved in the autocrine and paracrine regulation of the nigrostriatal dopaminergic synapses. Dopamine depletion, as in PD, increases angiotensin II expression, which stimulates or inhibits dopamine synthesis and is released via AT1 or AT2 receptors. Furthermore, angiotensin II AT1 receptors inhibit D1 receptor activation allosterically. Therefore, the RAS may have an important modulating role in the flow of information from the brain cortex to the basal ganglia. High angiotensin II levels might even aggravate neurodegeneration, activating the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase complex, which leads to increased reactive oxygen species production.

10 August 2023 in Frontiers in Neuroscience
Verified
Journal Article
Open access
TKTamara Kobiec
Tamara Kobiec
CMClaudia Mardaraz
Claudia Mardaraz
NTNicolás Toro-Urrego
Nicolás Toro-Urrego
RKRodolfo Kölliker-Frers
Rodolfo Kölliker-Frers
FCFrancisco Capani
Francisco Capani
MOMatilde Otero-Losada
Matilde Otero-Losada
Metabolic syndrome (MetS) is defined by the concurrence of different metabolic conditions: obesity, hypertension, dyslipidemia, and hyperglycemia. Its incidence has been increasingly rising over the past decades and has become a global health problem. MetS has deleterious consequences on the central nervous system (CNS) and neurological development. MetS can last several years or be lifelong, affecting the CNS in different ways and treatments can help manage condition, though there is no known cure. The early childhood years are extremely important in neurodevelopment, which extends beyond, encompassing a lifetime. Neuroplastic changes take place all life through — childhood, adolescence, adulthood, and old age — are highly sensitive to environmental input. Environmental factors have an important role in the etiopathogenesis and treatment of MetS, so environmental enrichment (EE) stands as a promising non-invasive therapeutic approach. While the EE paradigm has been designed for animal housing, its principles can be and actually are applied in cognitive, sensory, social, and physical stimulation programs for humans. Here, we briefly review the central milestones in neurodevelopment at each life stage, along with the research studies carried out on how MetS affects neurodevelopment at each life stage and the contributions that EE models can provide to improve health over the lifespan.

Verified
Journal Article
Open access
PDF file
NTNicolás Toro-Urrego
Nicolás Toro-Urrego
JLJuan P. Luaces
Juan P. Luaces
TKTamara Kobiec
Tamara Kobiec
LULucas Daniel Udovin
Lucas Daniel Udovin
SBSofía Bordet
Sofía Bordet
FCFrancisco Capani
Francisco Capani
Perinatal asphyxia (PA) is a clinical condition characterized by oxygen supply suspension before, during, or immediately after birth, and it is an important risk factor for neurodevelopmental damage. Its estimated 1/1000 live births incidence in developed countries rises to 5–10-fold in developing countries. Schizophrenia, cerebral palsy, mental retardation, epilepsy, blindness, and others are among the highly disabling chronic pathologies associated with PA. However, so far, there is no effective therapy to neutralize or reduce PA-induced harm. Selective regulators of estrogen activity in tissues and selective estrogen receptor modulators like raloxifene have shown neuroprotective activity in different pathological scenarios. Their effect on PA is yet unknown. The purpose of this paper is to examine whether raloxifene showed neuroprotection in an oxygen–glucose deprivation/reoxygenation astrocyte cell model. To study this issue, T98G cells in culture were treated with a glucose-free DMEM medium and incubated at 37 °C in a hypoxia chamber with 1% O2 for 3, 6, 12, and 24 h. Cultures were supplemented with raloxifene 10, and 100 nM during both glucose and oxygen deprivation and reoxygenation periods. Raloxifene 100 nM and 10 nM improved cell survival—65.34% and 70.56%, respectively, compared with the control cell groups. Mitochondrial membrane potential was preserved by 58.9% 10 nM raloxifene and 81.57% 100 nM raloxifene cotreatment. Raloxifene co-treatment reduced superoxide production by 72.72% and peroxide production by 57%. Mitochondrial mass was preserved by 47.4%, 75.5%, and 89% in T98G cells exposed to 6-h oxygen–glucose deprivation followed by 3, 6, and 9 h of reoxygenation, respectively. Therefore, raloxifene improved cell survival and mitochondrial membrane potential and reduced lipid peroxidation and reactive oxygen species (ROS) production, suggesting a direct effect on mitochondria. In this study, raloxifene protected oxygen–glucose-deprived astrocyte cells, used to mimic hypoxic–ischemic brain injury. Two examiners performed the qualitative assessment in a double-blind fashion.

10 January 2020 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
MOMatilde Otero-Losada
Matilde Otero-Losada
CLCanepa L
Canepa L
LULucas Udovin
Lucas Udovin
TKTamara Kobiec
Tamara Kobiec
NTNicolás Toro-Urrego
Nicolás Toro-Urrego
FCFrancisco Capani
Francisco Capani
Oxidative stress induced by the oxidative pathway dysregulation following ischemia/reperfusion has been proposed as an important cause of neuronal death and brain damage. The proteins of the thioredoxin (Trx) family are crucial mediators of protein function regulating the intracellular hydrogen peroxide levels and redox-sensitive post-translational protein changes. This study evaluates the long-term effects of common carotid artery ligation-induced ischemia/reperfusion on the protein expression and distribution of fourteen members of the Trx family and related proteins (Grx1, Grx2, Grx3, Grx5, Prx1, Prx2, Prx3, Prx4, Prx5, Prx6, Trx1, Trx2, TrxR1, TrxR2) in the most hypoxia susceptible rat brain areas, namely, cerebellum, corpus striatum, and the hippocampus. The thioredoxin proteins displayed a complex, cell-type, and tissue-specific expression pattern following ischemia/reperfusion. Even 60 days after ischemia/reperfusion, Western blot analysis showed a persistent expression of Trx1 and Grx2 in several brain areas. Thioredoxins might participate in the long-term restoration of redox signaling, and the recovery of the affected tissues.

26 November 2020
Verified
Book Chapter
Open access
PDF file
LULucas Daniel Udovin
Lucas Daniel Udovin
AAAndrea Aguilar
Andrea Aguilar
TKTamara Kobiec
Tamara Kobiec
MHMaría I. Herrera
María I. Herrera
Santiago Perez-LloretSantiago Perez-Lloret
Santiago Perez-Lloret
RFRodolfo A. Kölliker Frers
Rodolfo A. Kölliker Frers
Progressive neuronal loss is a typical characteristic of neurodegenerative diseases. In Parkinson’s disease, the loss of dopaminergic neurons in the basal ganglia results in impaired mobility and flawed muscle control. The loss of cholinergic neurons largely in the basal forebrain contributes to memory and attention deficits and the overall cognitive impairment in Alzheimer’s disease. This being said, neuroprotective drugs should be expected to preserve and/or restore the functions affected by neuronal loss, and substantially prevent cell death. The endocannabinoid system, comprising lipid mediators able to bind to and activate cannabinoid receptors, has emerged as a therapeutic target of potential interest in a variety of central nervous system diseases. Palmitoylethanolamide (PEA) is one of the most important endocannabinoids, which has a key role in modulating oxidative stress and inflammatory response with neuroprotective potential in neurological disorders. Neurodegenerative diseases undergo varied, progressive stages. The current therapeutical approaches are beginning to fall short when it comes to meet the expected results, urging to either develop or identify or develop new effective treatments. This chapter discusses the neuroprotective potential of new drugs, aiming to shed some light on their proposed mechanism of action and their effect in cellular and animal models of neurodegeneration.

1 January 2010 in Civilizar
Verified
Journal Article
Open access
PDF file
TKTamara Kobiec
Tamara Kobiec
En el presente trabajo se propone realizar una introducción al estudio del arte como una manera de encuentro con lo misterioso, lo inefable, basándose, por un lado, en los pensamientos de grandes artistas, filósofos y críticos de arte,tales como Tarkovski, Picasso, Unamuno y Steiner y, por otro, en los aportes realizados por la teología cristiana y la iconografía. Se realizará una lectura de la obra de arte en clave de esperanza: a través del silencio interior y la contemplación se puede encontrar la voz de aquella otra Belleza que atrae hacia Sí, mostrando cómo el Amor, la Belleza, la Bondad y la Verdad son diferentes caras de una misma realidad que supera la muerte, el dolor y la mentira.